XEDILOL 25 MG, Comprimé


--- Description
Pack Boîte de 30
Strength (Dosage) 25 MG
Laboratory SOTHEMA
Ingredients Carvédilol
Therapeutic class Bêtabloquant
ATC code C07AG02
PPH $5.94
PPV $9.50
Refundable Yes
Refund base $9.50
Refund rate $0.00
Table A
Marketing status Commercialized
Type Not specified
Uses Traitement de l'insuffisance cardiaque chronique stable, légère, modérée et sévère (fraction d'éjection ≤ 35%), en association avec le traitement conventionnel comportant inhibiteur de l'enzyme de conversion, diurétique et, le plus souvent, digitalique.
- Dans un programme d'études cliniques, chez des patients en insuffisance cardiaque légère à modérée, le carvédilol a permis de réduire la mortalité à 6 mois de 50%, IC 95% [33% - 75%].
- Dans l'étude COPERNICUS menée chez des patients en insuffisance cardiaque sévère non décompensée, le carvédilol a permis de réduire la mortalité à 1 an de 35%, IC 95% [19% - 48%].
Side effects

Medications with one or more of the ingredients above

Medications under one or more of the therapeutic classes above

Medications from the same laboratory

The materials provided by this website,, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.